These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 20736374)

  • 41. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.
    Tummalapalli P; Gondi CS; Dinh DH; Gujrati M; Rao JS
    Int J Oncol; 2007 Jul; 31(1):5-17. PubMed ID: 17549400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.
    Holst-Hansen C; Johannessen B; Høyer-Hansen G; Rømer J; Ellis V; Brünner N
    Clin Exp Metastasis; 1996 May; 14(3):297-307. PubMed ID: 8674284
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
    Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
    Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urokinase/urokinase receptor system: internalization/degradation of urokinase-serpin complexes: mechanism and regulation.
    Conese M; Blasi F
    Biol Chem Hoppe Seyler; 1995 Mar; 376(3):143-55. PubMed ID: 7612191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion.
    Zhao Y; Lyons CE; Xiao A; Templeton DJ; Sang QA; Brew K; Hussaini IM
    Biochem Biophys Res Commun; 2008 May; 369(4):1215-20. PubMed ID: 18355442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells.
    Rosenthal EL; Johnson TM; Allen ED; Apel IJ; Punturieri A; Weiss SJ
    Cancer Res; 1998 Nov; 58(22):5221-30. PubMed ID: 9823336
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.
    Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
    Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibitors of urokinase and thrombin in cultured neural cells.
    Wagner SL; Lau AL; Nguyen A; Mimuro J; Loskutoff DJ; Isackson PJ; Cunningham DD
    J Neurochem; 1991 Jan; 56(1):234-42. PubMed ID: 1987320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SPARC-induced migration of glioblastoma cell lines via uPA-uPAR signaling and activation of small GTPase RhoA.
    Kunigal S; Gondi CS; Gujrati M; Lakka SS; Dinh DH; Olivero WC; Rao JS
    Int J Oncol; 2006 Dec; 29(6):1349-57. PubMed ID: 17088972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. β-Elemene inhibits the metastasis of B16F10 melanoma cells by downregulation of the expression of uPA, uPAR, MMP-2, and MMP-9.
    Shi H; Liu L; Liu L; Geng J; Zhou Y; Chen L
    Melanoma Res; 2014 Apr; 24(2):99-107. PubMed ID: 24535052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer.
    Ahmed N; Pansino F; Baker M; Rice G; Quinn M
    J Cell Biochem; 2002; 84(4):675-86. PubMed ID: 11835393
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of metastasis, angiogenesis, and tumor growth by Chinese herbal cocktail Tien-Hsien Liquid.
    Chia JS; Du JL; Hsu WB; Sun A; Chiang CP; Wang WB
    BMC Cancer; 2010 Apr; 10():175. PubMed ID: 20429953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.
    Mori Y; Akita K; Tanida S; Ishida A; Toda M; Inoue M; Yashiro M; Sawada T; Hirakawa K; Nakada H
    J Biol Chem; 2014 Dec; 289(51):35193-204. PubMed ID: 25371209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Short chain fatty acids inhibit human (SW1116) colon cancer cell invasion by reducing urokinase plasminogen activator activity and stimulating TIMP-1 and TIMP-2 activities, rather than via MMP modulation.
    Emenaker NJ; Basson MD
    J Surg Res; 1998 Apr; 76(1):41-6. PubMed ID: 9695737
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression and activation of proteases in co-cultures.
    Paduch R; Kandefer-Szerszeń M
    Exp Toxicol Pathol; 2011 Jan; 63(1-2):79-87. PubMed ID: 19836935
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Docosahexaenoic Acid Downregulates EGF-Induced Urokinase Plasminogen Activator and Matrix Metalloproteinase 9 Expression by Inactivating EGFR/ErbB2 Signaling in SK-BR3 Breast Cancer Cells.
    Li CC; Yao HT; Cheng FJ; Hsieh YH; Lu CY; Wu CC; Liu KL; Chang JW
    Nutr Cancer; 2015; 67(5):771-82. PubMed ID: 25970488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specificity of serine proteinase/serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoprotein-receptor-related protein.
    Kasza A; Petersen HH; Heegaard CW; Oka K; Christensen A; Dubin A; Chan L; Andreasen PA
    Eur J Biochem; 1997 Sep; 248(2):270-81. PubMed ID: 9346278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.